NOTICE & PROXY STATEMENT

Company

GT Biopharma, Inc.

Filed

July 16, 1999

Period of Report

September 1, 1999

Accession Number

0001032210-99-001055

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →